LexDanaLexDanabeta
Inventor

Juan MARUGAN

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
Y02ATechnologies for adaptation to climate change22%
C07DHeterocyclic compounds11%
PatentTitleYear
12,208,093Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)202511,702,417Compounds for improving mRNA splicing202311,253,511Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to UNIV JOHNS HOPKINS (2)· patent assignee history
2022–2023Patents assigned to US HEALTH (2)· patent assignee history
2022Patents assigned to THE UNITED STATES OF AMERICA AS REPRESENTED BY TH (1)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to MASSACHUSETTS GEN HOSPITAL (1)· patent assignee history
2025Patents assigned to THE UNITED STATES OF AMERICA REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV JOHNS HOPKINS22022–2025
US HEALTH22022–2023
MASSACHUSETTS GEN HOSPITAL12023
THE UNITED STATES OF AMERICA AS REPRESENTED BY TH12022
THE UNITED STATES OF AMERICA REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES12025
Locations
LocationPatentsSpan
US32022–2025